Skip to main content

Infectious Neuropathies

  • Chapter
  • First Online:
Acquired Neuromuscular Disorders

Abstract

Infectious diseases frequently affect the peripheral nervous system by direct infiltration or indirect inflammatory response induced by the microorganisms. Peripheral neuropathies are commonly observed in the course of HIV infection and represent the major neurological complication of the disease. The heterogeneous spectrum makes the diagnosis challenging even for the expert neurologist and includes distal symmetric neuropathies, demyelinating neuropathies, mononeuritis multiplex, progressive polyradiculopathies, and diffuse infiltrative lymphocytosis syndrome. Peripheral neuropathy (PN) is one of the most frequently reported extrahepatic complications of HCV chronic infection, occurring in about 10% of HCV-infected patients. PN usually coexists with cryoglobulinemia and may manifest as chronic “length dependent” distal symmetrical sensorimotor or mainly sensory axonal polyneuropathy, “stocking-glove” asymmetric polyneuropathy, subacute mononeuropathy multiplex, or asymmetrical neuropathy involving large or small nerve fibers. Pure motor or demyelinating neuropathies and, rarely, cranial or autonomic neuropathies, have also been reported. Among the rarest causes of infectious neuropathies, leprosy and borreliosis are an important global health concern. The differential diagnosis is often difficult and sometimes, in particular in suspected neuritic form of leprosy, requires nerve biopsy and a detailed neuropathological analysis that can help for personalized therapy. With the COVID-19 pandemic, many cases of patients with peripheral nervous system involvement have been described, in the absence of a direct role of SARS-CoV-2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–36.

    Article  PubMed  Google Scholar 

  2. Robbins SJ, Shaheen AAM, Myers RP. Immunologic complications of the hepatitis C virus. Curr Hepatitis Rep. 2007;6:138–44.

    Article  Google Scholar 

  3. Bonetti B, Invernizzi F, Rizzuto N, et al. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol. 1997;73:145–54.

    Article  CAS  PubMed  Google Scholar 

  4. Vital C, Vital A, Canron MH, et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst. 2006;11:20–9.

    Article  PubMed  Google Scholar 

  5. Bonetti B, Scardoni M, Rizzuto N, et al. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch. 1999;434:533–5.

    Article  CAS  PubMed  Google Scholar 

  6. De Martino L, Sampaolo S, Tucci C, et al. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve. 2003;27:102–4.

    Article  PubMed  Google Scholar 

  7. Russi S, Sansonno D, Monaco S, et al. HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from HCV-infected patients with peripheral neuropathy. Neuropathol Appl Neurobiol. 2018;44:427–38.

    Article  CAS  PubMed  Google Scholar 

  8. Yoon MS, Obermann M, Dockweiler C, et al. Sensory neuropathy in patients with cryoglobulin negative hepatitis- C infection. J Neurol. 2011;258:80–8.

    Article  PubMed  Google Scholar 

  9. Bant A, Hurowitz B, Hassan N, et al. Complex regional pain syndrome (reflex sympathetic dystrophy) in a patient with essential mixed cryoglobulinemia and chronic hepatitis C. J Pak Med Assoc. 2007;57:96–8.

    PubMed  Google Scholar 

  10. Biasiotta A, Casato M, La Cesa S, et al. Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia. J Neurol. 2014;261:725–31.

    Article  CAS  PubMed  Google Scholar 

  11. Costa J, Resende C, De Carvalho M. Motor-axonal polyneuropathy associated with hepatitis C virus. Eur J Neurol. 2003;10:183–5.

    Article  CAS  PubMed  Google Scholar 

  12. Ammendola A, Sampaolo S, Migliaresi S, et al. Autonomic neuropathy in mixed cryoglobulinemia. J Neurol. 2007;254:215–9.

    Article  CAS  PubMed  Google Scholar 

  13. Tabor E. Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J Med Virol. 1987;21:207–16.

    Article  CAS  PubMed  Google Scholar 

  14. Khiani V, Kelly T, Shibli A, et al. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol. 2008;14:318–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. De Klippel N, Hautekeete ML, De Keyser J, et al. Guillain-Barré syndrome as the presenting manifestation of hepatitis C infection. Neurology. 1993;43:2143.

    Article  PubMed  Google Scholar 

  16. Corcia P, Barbereau D, Guennoc AM, et al. Improvement of a CIDP associated with hepatitis C virus infection using antiviral therapy. Neurology. 2004;63:179–80.

    Article  CAS  PubMed  Google Scholar 

  17. Hirotani M, Nakano H, Ura S, et al. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Intern Med. 2009;48:373–5.

    Article  PubMed  Google Scholar 

  18. Caporale CM, Capasso M, Ragno M, et al. Lewis-Sumner syndrome in hepatitis C virus infection: a possible pathogenetic association with therapeutic problems. Muscle Nerve. 2006;34:116–21.

    Article  PubMed  Google Scholar 

  19. Mariotto S, Ferrari S, Monaco S. HCV-related central and peripheral nervous system demyelinating disorders. Inflamm Allergy Drug Targets. 2014;13:299–304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dammacco F, Lauletta G, Russi S, et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med. 2019;19:1–21.

    Article  CAS  PubMed  Google Scholar 

  21. Benstead TJ, Chalk CH, Parks NE. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection. Cochrane Database Syst Rev. 2014;(12):CD010404.

    Google Scholar 

  22. Tu W, Johnson E, Fujiwara E, Gill MJ, et al. Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning. AIDS. 2021;35(11):1785–93. https://doi.org/10.1097/QAD.0000000000002955. Epub ahead of print.

    Article  CAS  PubMed  Google Scholar 

  23. Ferrari S, Vento S, Monaco S, et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc. 2006;2:213–9.

    Article  Google Scholar 

  24. Schütz SG, Robinson-Papp J. HIV-related neuropathy: current perspectives. HIV AIDS. 2013;5:243–51.

    Google Scholar 

  25. Cherry CL, Affandi JS, Imran D, et al. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009;73:315–20.

    Article  CAS  PubMed  Google Scholar 

  26. Ellis RJ, Rosario D, Clifford DB, et al.; CHARTER Study Group. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch Neurol. 2010;67:552–58.

    Google Scholar 

  27. Robinson-Papp J, Sharma S, Simpson DM, et al. Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy. J Neurovirol. 2013;19:172–80.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Cornblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology. 1988;38:794–6.

    Article  CAS  PubMed  Google Scholar 

  29. Rizzuto N, Cavallaro T, Monaco S, et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol. 1995;(90):244–50.

    Google Scholar 

  30. Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002;58:115–9.

    Article  CAS  PubMed  Google Scholar 

  31. Moss PJ, Huang W, Dawes J, et al. Macrophage-sensory neuronal interaction in HIV-1 gp120-induced neurotoxicity. Br J Anaesth. 2015;114:499–508.

    Article  CAS  PubMed  Google Scholar 

  32. Roda RH, Bargiela D, Chen W, et al. Large mitochondrial DNA deletions in HIV sensory neuropathy. Neurology. 2021;97(2):e156–65. https://doi.org/10.1212/WNL.0000000000012142. Epub ahead of print.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Mou J, Paillard F, Turnbull B, et al. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza clinical trials database. Pain. 2013;154:1632–9.

    Article  CAS  PubMed  Google Scholar 

  34. Simpson DM, Schifitto G, Clifford DB, Murphy TK, Durso-De Cruz E, Glue P, Whalen E, Emir B, Scott GN, Freeman R, 1066 HIV Neuropathy Study Group. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010;74(5):413–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68:515–52.

    Article  CAS  PubMed  Google Scholar 

  36. Schifitto G, Yiannoutsos C, Simpson DM, et al.; AIDS Clinical Trials Group Team 291. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology. 2001;57:1313–16.

    Google Scholar 

  37. Hiraga A, Kuwabara S, Nakamura A, et al. Fisher/Gullain-Barré overlap syndrome in advanced AIDS. J Neurol Sci. 2007;258:148–50.

    Article  PubMed  Google Scholar 

  38. Brannagan TH 3rd, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003;208:39–42.

    Article  PubMed  Google Scholar 

  39. Ferrari S, Lanzafame M, Faggian F, et al. Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. Scand J Infect Dis. 2004;36:392–293.

    Article  PubMed  Google Scholar 

  40. Miller RF, Fox JD, Thomas P, et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry. 1996;61:456–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Kameda K, Shirano M, Hadano Y, et al. Cytomegalovirus polyradiculopathy in three Japanese patients with AIDS. Intern Med. 2015;54:513–8.

    Article  CAS  PubMed  Google Scholar 

  42. Ghrenassia E, Martis N, Boyer J, et al. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun. 2015;59:19–25.

    Article  CAS  PubMed  Google Scholar 

  43. Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol. 1997;41:438–45.

    Article  CAS  PubMed  Google Scholar 

  44. WHO. Global leprosy update, 2013; reducing disease burden. Wkly Epidemiol Rec. 2014;89:389–400.

    Google Scholar 

  45. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34:255–73.

    CAS  PubMed  Google Scholar 

  46. de Freitas MR, Nascimento OJ, Quaglino EA, et al. Small-fiber polyneuropathy in leprosy without skin changes: study of 17 cases. Arq Neuropsiquiatr. 2003;61:542–5.

    Article  PubMed  Google Scholar 

  47. Visser LH, Jain S, Lokesh B, et al. Morphological changes of the epineurium in leprosy: a new finding detected by high-resolution sonography. Muscle Nerve. 2012;46:38–41.

    Article  PubMed  Google Scholar 

  48. Kulshreshtha D, Malhotra KP, Malhotra HS, et al. Mandating nerve biopsy: a step towards personalizing therapy in pureneuritic leprosy. J Peripher Nerv Syst. 2018;23:190–6.

    Article  PubMed  Google Scholar 

  49. Dryden MS, Saeed K, Ogborn S, et al. Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy. Epidemiol Infect. 2015;143:561–72.

    Article  CAS  PubMed  Google Scholar 

  50. van Erp WS, Bakker NA, Aries MJ, et al. Opsoclonus and multiple cranial neuropathy as a manifestation of neuroborreliosis. Neurology. 2011;77:1013–4.

    Article  PubMed  Google Scholar 

  51. Muley SA, Parry GJ. Antibiotic responsive demyelinating neuropathy related to Lyme disease. Neurology. 2009;72:1786–7.

    Article  PubMed  Google Scholar 

  52. Halperin JJ, Little BW, Coyle PK, et al. Lyme disease: cause of a treatable peripheral neuropathy. Neurology. 1987;37:1700–6.

    Article  CAS  PubMed  Google Scholar 

  53. Mygland A, Skarpaas T, Ljøstad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006;13:1213–5.

    Article  CAS  PubMed  Google Scholar 

  54. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323:1438–44.

    Article  CAS  PubMed  Google Scholar 

  55. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931–41. https://doi.org/10.1016/S1474-4422(11)70178-8.

    Article  PubMed  Google Scholar 

  56. Cabañes-Martínez L, Villadóniga M, González-Rodríguez L, et al. Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol. 2020;131(12):2809–16. https://doi.org/10.1016/j.clinph.2020.09.017.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Frithiof R, Rostami E, Kumlien E, et al. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: a prospective study. Clin Neurophysiol. 2021;132(7):1733–40. https://doi.org/10.1016/j.clinph.2021.03.016.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Filosto M, Cotti Piccinelli S, Gazzina S, et al. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92(7):751–6. https://doi.org/10.1136/jnnp-2020-324837.

    Article  PubMed  Google Scholar 

  59. Gigli GL, Bax F, Marini A, Pellitteri G, Scalise A, Surcinelli A, Valente M. Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? J Neurol. 2021;268(4):1195–7. https://doi.org/10.1007/s00415-020-09911-3.

    Article  CAS  PubMed  Google Scholar 

  60. Fragiel M, Miró Ò, Llorens P, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Ann Neurol. 2021;89(3):598–603. https://doi.org/10.1002/ana.25987.

    Article  CAS  PubMed  Google Scholar 

  61. Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021;144(2):682–93. https://doi.org/10.1093/brain/awaa433.

    Article  PubMed  Google Scholar 

  62. Aladawi M, Elfil M, Abu-Esheh B, et al. Guillain Barre syndrome as a complication of COVID-19: a systematic review. Can J Neurol Sci. 2021;5:1–35. https://doi.org/10.1017/cjn.2021.102. Epub ahead of print. PMID: 33949300.

    Article  CAS  Google Scholar 

  63. Uncini A, Foresti C, Frigeni B, et al. Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection. Neurophysiol Clin. 2021;51(2):183–91. https://doi.org/10.1016/j.neucli.2021.02.001.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Abu-Rumeileh S, Garibashvili T, Ruf W, et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci. 2020;418:117106. https://doi.org/10.1016/j.jns.2020.117106. Epub 2020 Sep 2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Van Looy E, Veenker L, Steyaert A, et al. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy. J Neurol. 2021;268(9):3129–31. https://doi.org/10.1007/s00415-021-10417-9. Epub ahead of print.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Brugliera L, Filippi M, Del Carro U, et al. Nerve compression injuries after prolonged prone position ventilation in patients with SARS-CoV-2: a case series. Arch Phys Med Rehabil. 2021;102(3):359–62. https://doi.org/10.1016/j.apmr.2020.10.131.

    Article  PubMed  Google Scholar 

  67. Malik GR, Wolfe AR, Soriano R, Rydberg L, et al. Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome. Br J Anaesth. 2020;125(6):e478–80. https://doi.org/10.1016/j.bja.2020.08.045.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergio Ferrari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ferrari, S., Mariotto, S., Cavallaro, T., Fabrizi, G.M., Monaco, S. (2022). Infectious Neuropathies. In: Angelini, C. (eds) Acquired Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-06731-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-06731-0_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-06730-3

  • Online ISBN: 978-3-031-06731-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics